User:Mr. Ibrahem/Ticagrelor

Ticagrelor, sold under the brand name Brilinta among others, is a medication used in acute coronary syndrome to prevent stroke and heart attacks. It is generally used with aspirin. It is taken by mouth.

Common side effects include bleeding and shortness of breath. Other side effects may include cough, diarrhea, and low blood pressure. It is a platelet aggregation inhibitor, specifically a adenosine diphosphate receptor inhibitor, which works by blocking ADP from attaching to platelets.

Ticagrelor was approved for medical use in Europe 2010, and in the United States in 2011. In the United Kingdom 4 weeks of medication costs the NHS about £55 as of 2021. In the United States this amount costs about 380 USD as of 2021.